Mustafa Özdoğan

3.2k total citations
106 papers, 1.9k citations indexed

About

Mustafa Özdoğan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mustafa Özdoğan has authored 106 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in Mustafa Özdoğan's work include Lung Cancer Treatments and Mutations (11 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Diagnosis and Treatment (6 papers). Mustafa Özdoğan is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Diagnosis and Treatment (6 papers). Mustafa Özdoğan collaborates with scholars based in Türkiye, United Kingdom and Greece. Mustafa Özdoğan's co-authors include Erkan Çoban, G. Yazicioglu, Ayşen Timurağaoğlu, Burhan Savaş, Hakan Bozcuk, Mehmet Artaç, Mustafa Samur, Erdinç Nayır, Hakan Bozcuk and Hasan Mutlu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Mustafa Özdoğan

100 papers receiving 1.8k citations

Peers

Mustafa Özdoğan
Comparison fields: 5 of 129
  • Oncology 736
  • Molecular Biology 317
  • Endocrinology, Diabetes and Metabolism 292
  • Epidemiology 251
  • Cardiology and Cardiovascular Medicine 247
Paul Carter United Kingdom
Pilar Díz Spain
Rikje Ruiter Netherlands
Francesca Martini Italy
Olufemi J. Ogunbiyi Nigeria
V. Beral United Kingdom
David S. López United States
Egidio Celentano Italy
Fangjian Guo United States
Ji Eun Yun South Korea
Paul Carter United Kingdom View profile →
Citations per field, relative to Mustafa Özdoğan
Mustafa Özdoğan · 1×
Citations per year, relative to Mustafa Özdoğan
Mustafa Özdoğan · 1×

Countries citing papers authored by Mustafa Özdoğan

Since Specialization
Citations

This map shows the geographic impact of Mustafa Özdoğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Özdoğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Özdoğan more than expected).

Fields of papers citing papers by Mustafa Özdoğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mustafa Özdoğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Özdoğan. The network helps show where Mustafa Özdoğan may publish in the future.

Co-authorship network of co-authors of Mustafa Özdoğan

This figure shows the co-authorship network connecting the top 25 collaborators of Mustafa Özdoğan. A scholar is included among the top collaborators of Mustafa Özdoğan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mustafa Özdoğan. Mustafa Özdoğan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Molecular Insights into HPV-Driven Head and Neck Cancers: From Viral Oncoproteins to Precision Therapeutics Viruses Mustafa Özdoğan, G. Hossein Ashrafi et al. 0
2 P044: Examining the Correlation and Concordance Between Ki-67 Expression and Oncotype DX Recurrence Score: Findings from a Multicenter Study in Turkey The Breast Cihan Uras, Mahmut Çerkez Ergören et al. 0
3 Case report: Immunotherapy guided by molecular profiling of tumors: illustrative cases and literature review Frontiers in Medicine Mustafa Özdoğan, Eirini Papadopoulou et al. 1
4 Genetic testing in patients with pancreatic cancer to reveal pathogenic variants in cancer susceptibility genes. Journal of Clinical Oncology Κωνσταντίνος Αγιαννιτόπουλος, Georgios Tsaousis et al. 1
5 Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer Journal of Cancer Research and Therapeutics Hasan Mutlu, Mehmet Artaç et al. 5
6 Dietary and Demographical Risk Factors for Oesophageal Squamous Cell Carcinoma in the Eastern Anatolian Region of Turkey Where Upper Gastrointestinal Cancers are Endemic Asian Pacific Journal of Cancer Prevention Didem Taştekin, Duygu Sezen et al. 16
7 Retrospective analysis of third-line chemotherapy in advanced non-small cell lung cancer Journal of Cancer Research and Therapeutics Mükremın Uysal, Mustafa Özdoğan et al. 4
8 The importance of COX-2 expression as prognostic factor in early breast cancer. PubMed Mükremın Uysal, Hakan Bozcuk et al. 12
9 Can positron emission tomography-computed tomography predict response in locally advanced rectal cancer patients treated with induction folinic acid and 5-florouracil? Indian Journal of Cancer Şeyda Gündüz, Mükremın Uysal et al. 1
10 Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs) Breast Cancer Mehmet Artaç, Hakan Bozcuk et al. 10
11 Purified Micronized Flavonoid Fraction Ameliorates the Injury of Spleen and Ileum Secondary to Hepatic Ischemia–Reperfusion in Rats Digestive Diseases and Sciences Fahrettin Yıldız, Alpaslan Terzi et al. 9
12 Protective effects of resveratrol on small intestines against intestinal ischemia–reperfusion injury in rats Journal of Gastroenterology and Hepatology Fahrettin Yıldız, Alpaslan Terzi et al. 24
13 Cisplatin cytotoxicity is enhanced with zoledronic acid in A549 lung cancer cell line: Preliminary results of an in vitro study Cell Biology International Hakan Bozcuk, Durmuş Burgucu et al. 34
14 Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer. PubMed Hakan Bozcuk, Aziz Gümüş et al. 7
15 The mean platelet volume in patients with obesity International Journal of Clinical Practice Erkan Çoban, Mustafa Özdoğan et al. 234
16 The plasma levels of plasminogen activator inhibitor-1 in subjects with white coat hypertension International Journal of Clinical Practice Erkan Çoban, Mustafa Özdoğan 9
17 A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients International Journal of Clinical Practice Hakan Bozcuk, Mustafa Samur et al. 33
18 A Novel Method of Reporting c-erbB-2 Overexpression: Correlation with Grade But Not with Other Prognostic Parameters in Breast Cancer* TURKISH JOURNAL OF MEDICAL SCIENCES Mustafa Samur, Şeyda Karaveli et al. 2
19 Durable Remission of Leptomeningeal Metastasis of Breast Cancer with Letrozole: a Case Report and Implications of Biomarkers on Treatment Selection Japanese Journal of Clinical Oncology Mustafa Özdoğan 36
20 Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators Breast Cancer Research and Treatment Hakan Bozcuk, Elif Peştereli et al. 27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Carter Breakdown of academic impact, for papers by Pilar Díz Breakdown of academic impact, for papers by Rikje Ruiter Breakdown of academic impact, for papers by Francesca Martini Breakdown of academic impact, for papers by Olufemi J. Ogunbiyi Breakdown of academic impact, for papers by V. Beral Breakdown of academic impact, for papers by David S. López Breakdown of academic impact, for papers by Egidio Celentano Breakdown of academic impact, for papers by Fangjian Guo Breakdown of academic impact, for papers by Ji Eun Yun
Rankless by CCL
2026